Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model (Q33788921)

29 July 2017

Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model (English)

1 reference

Francois van der Westhuizen

29 July 2017

1 reference

Du Toit Loots

6

0 references

object named as

Francois H van der Westhuizen

3

0 references

author name string

Marlien Pieters

1

1 reference

29 July 2017

Namukolo Covic

2

1 reference

29 July 2017

Chandrasekaran Nagaswami

4

1 reference

29 July 2017

Yelena Baras

5

1 reference

29 July 2017

Johann C Jerling

7

1 reference

29 July 2017

Dale Elgar

8

1 reference

29 July 2017

Kathryn S Edmondson

9

1 reference

29 July 2017

Danie G van Zyl

10

1 reference

29 July 2017

Paul Rheeder

11

1 reference

29 July 2017

John W Weisel

12

1 reference

29 July 2017

1 April 2008

1 reference

29 July 2017

10

1 reference

Thrombosis and Haemostasis

inferred from page(s)

published in

1 reference

29 July 2017

99

1 reference

29 July 2017

691-700

1 reference

29 July 2017

4

1 reference

describes a project that uses

29 July 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC2854507/fullTextXML

inferred from PubMed Central ID database lookup

cites work

The mechanical properties of fibrin for basic scientists and clinicians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

Fibrinogen and fibrin clot structure in diabetes

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

Diabetes mellitus: a hypercoagulable state

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

The relation between insulin resistance and cardiovascular complications of the insulin resistance syndrome.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

Structural origins of fibrin clot rheology

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

Cl- regulates the structure of the fibrin clot

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentrations.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

Studies on fibrin network structure in human plasma. Part II - Clinical application: Diabetes and antidiabetic drugs

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

The influence of type 2 diabetes on fibrin structure and function

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

Increased plasma fibrin gel porosity in patients with Type I diabetes during continuous subcutaneous insulin infusion

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

The ultrastructure of fibrinogen Caracas II molecules, fibers, and clots.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

Carboxyl-terminal portions of the alpha chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated alpha C fragments on polymerization.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2854507

Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy

30 October 2018

1 reference

12 December 2020

Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations

1 reference

12 December 2020

Nonenzymatic Glycosylation Reduces the Susceptibility of Fibrin to Degradation by Plasmin

1 reference

12 December 2020

Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis

1 reference

12 December 2020

The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects

1 reference

12 December 2020

In vitro preparation of nonenzymatically glucosylated human transferrin, alpha 2-macroglobulin, and fibrinogen with preservation of function

1 reference

12 December 2020

Properties of in vitro nonenzymatically glycated plasma fibrinogens

1 reference

12 December 2020

Glycosylation of human fibrinogen and fibrin in vitro. Its consequences on the properties of fibrin(ogen)

1 reference

12 December 2020

Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers

1 reference

12 December 2020

Polymerisation and crosslinking of fibrin monomers in diabetes mellitus

1 reference

12 December 2020

Fibrin gel network characteristics and coronary heart disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and coronary atherosclerosis

1 reference

12 December 2020

Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation

1 reference

12 December 2020

Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation

1 reference

12 December 2020

Calcium ion-dependent monoclonal antibody against human fibrinogen: preparation, characterization, and application to fibrinogen purification

1 reference

12 December 2020

Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. Study with confocal microscopy

1 reference

12 December 2020

Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age

1 reference

12 December 2020

Altered properties of the fibrin gel structure in patients with IDDM

1 reference

12 December 2020

Glycated proteins modulate tissue-plasminogen activator-catalyzed plasminogen activation

1 reference

12 December 2020

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

12 December 2020

Identifiers

DOI

10.1160/TH07-11-0699

1 reference

29 July 2017

1 reference

29 July 2017

1 reference